FEATURED CONTRIBUTED CONTENT

Commercializing Cell and Gene Therapies


Commercializing Cell and Gene Therapies

Cell and gene therapies coming to market hold the potential to redefine every commercialization paradigm – from how products come to market, to how the therapies are transported, to how patients and providers are supported. What can therapy innovators do to ensure commercial success? Experts at AmerisourceBergen have released a new, interactive whitepaper in which […]

October 6, 2017 More Clinical »
Discover the Megatrends Remapping the Pharmaceutical Market


Discover the Megatrends Remapping the Pharmaceutical Market

New Manatt Health Webinar Reveals the Megatrends Reinventing the Ways Your Patient, Provider and Payer Customers Think—and How You Should Respond to Succeed. Click to Register Free. From the continued evolution of new payment models to the explosion of mHealth to the creation of personalized therapies, powerful trends and disruptive innovations are converging to reshape […]

November 14, 2017 More Clinical »
Early Access – Where do Payers Stand?


Early Access – Where do Payers Stand?

This article covers 5 key issues related to payers’ treatment of pricing and reimbursement. Issue 1: It is not rocket science: Less substantiated value propositions for molecules that launch with Phase II data translate into less positive benefit assessments by national agencies. Issue 2: In 2017, payers across the EU and US have shown significant […]

September 12, 2017 More Clinical »
Connecting the Dots: Analyzing the Power of Customer Networks


Connecting the Dots: Analyzing the Power of Customer Networks

New report: How one company increased revenue by 33% leveraging customer network relationships Breaking the ice can be hard. Establishing new relationships, including potential customer relationships, is easier when you get an introduction from someone in your shared network. Those common connections open the door to more personal interactions – and result in improved sales. […]

September 26, 2017 More Clinical »
Data-Driven Patient Outreach


Data-Driven Patient Outreach

How Properly Timed, Targeted Engagement Tactics can Increase Adherence and Brand Revenue Co-pay savings programs are powerful brand marketing tools; not just because of their ability to introduce new patients to therapy, but also due to the wealth of patient behavior data that they generate. These data, when used properly, can drive targeted patient engagement strategies that are uniquely […]

October 17, 2017 More Clinical »
How to Navigate Specialty Logistics for Cell and Gene Therapies


How to Navigate Specialty Logistics for Cell and Gene Therapies

Sam Herbert, President of World Courier, a part of AmerisourceBergen and global leader in specialty logistics, discusses tips that can guide innovators in navigating the logistics hurdles of novel therapies, such as cell and gene therapies, so that they get into the hands of the patients who need them most. You can also read a […]

October 6, 2017 More Clinical »
Digitizing Clinical Research Processes – The New Frontier


Digitizing Clinical Research Processes – The New Frontier

One in three people will be diagnosed with cancer in their lifetime, but according to the NIH, only 3-5% of adult cancer patients participate in clinical trials. Advancing therapies in oncology and other disease areas is at the forefront of academic and commercial R&D. But enrollment and site initiation is often hindered by daunting, time […]

November 15, 2017 More Clinical »
How Big Data is Actively Impacting Healthcare


How Big Data is Actively Impacting Healthcare

Big data has become a buzzword in the industry, Cello Health’s Elizabeth, Jackie, and Kimberly predict how it will actively impact the future of healthcare, providing real world examples. From streamlining the development of new therapies, helping to drive personalized treatment decisions, and facilitating demonstration of the real-world value of pharmaceutical products, big data should […]

September 6, 2017 More Clinical »
The New Reality: Maximizing Value in Rare Disease Launches


The New Reality: Maximizing Value in Rare Disease Launches

The rare disease landscape is changing: with assets being granted expedited review, launch is no longer a fixed point in time, and research and development (R&D), medical affairs, and commercial teams need to collaborate early in the process to reach critical consensus on where to focus, when to engage key health care provider (HCP) stakeholders, […]

September 7, 2017 More Clinical »
Locating Patients with Rare Diseases


Locating Patients with Rare Diseases

Why a Qualitative Lead Generation Approach Is a Must-Have Component of Any Orphan Drug Sales Strategy Finding patients with rare diseases requires both a quantitative and a qualitative approach. By taking analytics one step further and using a hands-on approach, TrialCard’s Virtual Engagement team has identified health care professionals (HCPs) currently treating patients with rare […]

October 13, 2017 More Clinical »
FEEDBACK